Today: 22 May 2026
Record defence IPO: Czech arms group CSG jumps as much as 32% in Amsterdam debut
23 January 2026
2 mins read

Record defence IPO: Czech arms group CSG jumps as much as 32% in Amsterdam debut

AMSTERDAM, Jan 23, 2026, 11:41 CET

  • CSG shares surged as much as 32% after pricing came in at 25 euros per share
  • The IPO raised 3.3 billion euros, and could reach about 3.8 billion euros if the over-allotment option is fully utilized
  • The debut taps into a rally in European defence stocks, sparked by governments ramping up budgets and restocking arsenals

Shares of Czech defence firm Czechoslovak Group (CSG) jumped as much as 32% on Friday in their Amsterdam debut, following a record-setting IPO. By 0812 GMT, the stock was up 20.9% at 30.235 euros, after opening at 25 euros per share. The offering valued the Prague-based company at 25 billion euros and raised up to 3.8 billion euros.

As investors rush into European defence stocks, betting on sustained government spending amid the Ukraine conflict, a new float emerges. The Stoxx Europe Aerospace and Defence index jumped over 10% in January, building on a 57% surge in 2025, according to the Financial Times. The report singled out Rheinmetall, which soared 154% last year.

Michal Strnad sold €2.55 billion worth of shares as part of a €3.3 billion deal, with the company itself raising €750 million. Banks may add more shares to the market if they exercise an over-allotment option. “Today marks a historic milestone for CSG,” Strnad said. Raphael Thuin, head of capital markets strategies at Tikehau Capital, noted, “The investment case for European defence companies remains robust, with recent debates around Nato and Greenland only intensifying interest in the sector.” https://www.theedgesingapore.com/news/euro…

An IPO signals a company’s first share sale on a stock exchange. CSG floated up to 15.2% of its stock, combining 30 million new shares with as many as 122 million existing shares sold by Strnad. Barclays analyst Afonso Osorio remarked, “Years of under-investment in Europe are long behind us.” Czech brokerage Patria pegged the 2026 EV/EBITDA multiple at under 14—a measure of enterprise value including debt against earnings before interest, taxes, depreciation, and amortization—calling it “an attractive entry point given the above-average growth outlook and premium operating profitability.” https://www.reuters.com/business/aerospace…

CSG, listed on Euronext Amsterdam with the ticker CSG, priced its IPO at 25 euros, the exchange’s IPO showcase page shows. ING Bank is the sponsor.

Artisan Partners, BlackRock, and Al-Rayyan Holdings, part of the Qatar Investment Authority, each took a 300 million euro slice as cornerstone investors. Their commitments came before trading kicked off. A bookrunner said order books flooded in swiftly earlier this week.

CSG makes both large- and small-calibre ammunition, armored vehicles, and radars. It’s been a major military gear supplier to Ukraine. Strnad said the listing would give the group capital to finance acquisitions. In 2024, it snapped up U.S. small-ammunition maker Kinetic for $2.2 billion, adding brands such as Remington to its lineup.

CSG’s prospectus forecasts revenue hitting between 7.4 billion and 7.6 billion euros this year, up from just over 6.4 billion euros expected in 2025. The company also targets an operating margin ranging from 24% to 25%. By September 2025, net debt stood at 3.59 billion euros, with a dividend payout ratio planned between 30% and 40% beginning in 2027.

CSG’s debut has become a reference point for upcoming defence listings in Europe, including Franco-German tankmaker KNDS and Britain’s Doncasters Group. Bankers say the pipeline remains sparse, boosting appeal for investors keen to jump in early.

The sector’s rally could stall. Defence budgets fluctuate with political winds, and any drop in demand or a shift in the Ukraine conflict might squeeze orders, margins, and valuations for the new stock. Add to that CSG’s significant debt load, which leaves little room for mistakes.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap
Previous Story

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing
Next Story

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

Go toTop